Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Watanakunakorn

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
The Journal of Antimicrobial Chemotherapy|May 1, 1979
Are wall-defective microbial variants important in clinical infectious diseases?C Watanakunakorn
American Heart Journal|October 1, 1988
Streptococcus bovis endocarditis associated with villous adenoma following colonoscopyC Watanakunakorn
Scandinavian Journal of Infectious Diseases|January 1, 1984
Antimicrobial susceptibility of 200 blood isolates of coagulase-negative staphylococci to 20 antimicrobial agentsC Watanakunakorn
Infection and Immunity|March 1, 1971
Cycloserine Induction, Propagation, and Antimicrobial Susceptibility of Wall-Defective Staphylococcus aureusC Watanakunakorn
Infection and Immunity|May 1, 1971
Vancomycin Induction of L Colonies of Staphylococcus aureusC Watanakunakorn
The Journal of Antimicrobial Chemotherapy|March 1, 1992
Comparison of LY264826-gentamicin with vancomycin-gentamicin against enterococci from blood culturesC Watanakunakorn
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2000
Meningitis due to viridans streptococciC Watanakunakorn
Chest|December 15, 2000
Acute exacerbation of chronic bronchitis: what is the clinical significance of pathogenic bacteria in sputum cultures?C Watanakunakorn
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 1, 1991
In vitro activity of the new glycopeptide LY264826 versus vancomycin against clinical isolates of enterococciC Watanakunakorn
The American Journal of Medicine|June 1, 1978
Infective endocarditis as a result of medical progressC Watanakunakorn
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
The Journal of Antimicrobial Chemotherapy|May 1, 1979
Are wall-defective microbial variants important in clinical infectious diseases?C Watanakunakorn
American Heart Journal|October 1, 1988
Streptococcus bovis endocarditis associated with villous adenoma following colonoscopyC Watanakunakorn
Scandinavian Journal of Infectious Diseases|January 1, 1984
Antimicrobial susceptibility of 200 blood isolates of coagulase-negative staphylococci to 20 antimicrobial agentsC Watanakunakorn
Infection and Immunity|March 1, 1971
Cycloserine Induction, Propagation, and Antimicrobial Susceptibility of Wall-Defective Staphylococcus aureusC Watanakunakorn
Infection and Immunity|May 1, 1971
Vancomycin Induction of L Colonies of Staphylococcus aureusC Watanakunakorn
The Journal of Antimicrobial Chemotherapy|March 1, 1992
Comparison of LY264826-gentamicin with vancomycin-gentamicin against enterococci from blood culturesC Watanakunakorn
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2000
Meningitis due to viridans streptococciC Watanakunakorn
Chest|December 15, 2000
Acute exacerbation of chronic bronchitis: what is the clinical significance of pathogenic bacteria in sputum cultures?C Watanakunakorn
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 1, 1991
In vitro activity of the new glycopeptide LY264826 versus vancomycin against clinical isolates of enterococciC Watanakunakorn
The American Journal of Medicine|June 1, 1978
Infective endocarditis as a result of medical progressC Watanakunakorn
Pageof 19